Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-045462
Filing Date
2012-08-14
Accepted
2012-08-14 16:38:33
Documents
1
Period of Report
2012-08-13

Document Format Files

Seq Description Document Type Size
1 ISSANCE OF STOCK OPTIONS rrd352710.html 4  
1 ISSANCE OF STOCK OPTIONS rrd352710.xml 4 3957
  Complete submission text file 0001181431-12-045462.txt   5361
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Issuer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PDL BIOPHARMA 932 SOUTHWOOD BOULEVARD INCLINE VILLAGE NV 89451
Business Address
LARSON CHRISTINE R (Reporting) CIK: 0001270013 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34207 | Film No.: 121033601